This wiki has undergone a migration to Confluence found Here
Difference between revisions of "HL7 Stability Standard Implementation Guide Teleconference Minutes 2011-04-18"
Jump to navigation
Jump to search
NRGregory57 (talk | contribs) (Created page with "==HL7 Stability Standard Pilot/Implementation Guide Teleconference Minutes== '''April 18, 2011''' Attendees: Norman Gregory (CVM), Elizabeth Cormier (CVM), David Longstaff (CVM...") |
NRGregory57 (talk | contribs) |
||
| Line 11: | Line 11: | ||
*In the validation document changed 3.3.1 3 to read id is unique and can not be used as an id in other documents, sections and any other ids. | *In the validation document changed 3.3.1 3 to read id is unique and can not be used as an id in other documents, sections and any other ids. | ||
*In the validation document did a find and delete "id does not have an extension". | *In the validation document did a find and delete "id does not have an extension". | ||
| − | * | + | *The attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6232/8244/ValidationProcReview.doc) is the validation review document and the other attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6233/8245/HL7DrugStabilityReportingValidationProcedures3-7-11JSMnotes.doc) is the HL7 Drug Stability Reporting Validation Procedures with Josh's edits and questions. |
'''Agenda for April 25, 2011 Teleconference:''' | '''Agenda for April 25, 2011 Teleconference:''' | ||
Latest revision as of 02:56, 20 April 2011
HL7 Stability Standard Pilot/Implementation Guide Teleconference Minutes
April 18, 2011
Attendees:
Norman Gregory (CVM), Elizabeth Cormier (CVM), David Longstaff (CVM), Tim Lee (CBER), Tena Wei (CDRH), Catherine Hosage-Norman (Sunovion), Mike Mlodzik (Boehringer Ingelheim Vetmedica, Inc.), Mike Yang (ScienTek Software), Edward Pec (Abbott Laboratories), Art Griesser (Promethues), Chuck Warner (Beckloff Associates), Sandra Spiewak (Reed Technology and Information Services Inc.), and Tom East (Tom East Consulting)
- In the validation document changed 1.1 to read "XML is well formed and valid against the schema, and any schematron rules embedded there in".
- In the validation document changed 1.2 to read "There are no data elements and attributes in addition to those described in this document (e.g., You can not create data elements and attributes that are not present in the schema)."
- In the validation document deleted 3.3.1 2 and renumbered.
- In the validation document changed 3.3.1 3 to read id is unique and can not be used as an id in other documents, sections and any other ids.
- In the validation document did a find and delete "id does not have an extension".
- The attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6232/8244/ValidationProcReview.doc) is the validation review document and the other attached file (http://gforge.hl7.org/gf/download/docmanfileversion/6233/8245/HL7DrugStabilityReportingValidationProcedures3-7-11JSMnotes.doc) is the HL7 Drug Stability Reporting Validation Procedures with Josh's edits and questions.
Agenda for April 25, 2011 Teleconference:
- We will continue to use Adobe connect (to join the meeting: https://collaboration.fda.gov/hl7/)
- Schematron progress update
- Outstanding issues
